Back

Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease 1 Intervention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ricardo Carvalheiro

University Hospital Lisboa Central, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
Post- TAVI care: assessing the need for cardiac device implantation
Doctor A. Abrantes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter mitral valve repair: 10-year experience from a Portuguese tertiary care center
Doctor F. Barbas De Albuquerque (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Shor-term and long-term outcomes in transcatheter versus surgical aortic valve replacement
Ms G. Ramantauskaite (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
30-day and 1-year mortality after transcatheter aortic valve replacement: the impact of balloon aortic valvuloplasty as a bridging therapy in a Portuguese tertiary center
Doctor F. Barbas De Albuquerque (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Right ventricular ejection fraction assessed by cardiac computed tomography in patients undergoing transcatheter aortic valve replacement
Doctor V. Lopes (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular heart disease 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Differences in outcomes between percutaneous coronary intervention of bystander coronary lesions and medical therapy in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Optimal timing of percutaneous coronary intervention in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Shor-term and long-term outcomes in transcatheter versus surgical aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources